Nurse Practitioner, Acute Care · Philadelphia, PA
NPI
1053021030
Since 2022
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Spruce St
Philadelphia, PA, 19104
Phone (215) 662-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,072
29 services
Medicare patients, 2024
13
Average age 54
Drug cost, 2024
$1.1M
2,181 prescriptions
Company payments, 2023
$134
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer L Vise prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 164 prescriptions and refills. In total Jennifer L Vise wrote 2,181 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 164 | 354 | 53 | $1,201 |
| Prednisone Generic | 164 | 366 | 50 | $1,187 |
| Valacyclovir Valacyclovir Hcl | 137 | 273 | 35 | $4,619 |
| Tacrolimus Generic | 126 | 281 | 26 | $22K |
| Azithromycin Generic | 115 | 284 | 39 | $2,434 |
| Metoprolol Succinate Generic | 106 | 224 | 32 | $1,782 |
| Omeprazole Generic | 103 | 213 | 29 | $1,209 |
| Prevymis Letermovir | 90 | 90 | 12 | $620K |
| Famotidine Generic | 79 | 143 | 24 | $658 |
| Gabapentin Generic | 63 | 98 | 17 | $855 |
| Atovaquone Generic | 55 | 78 | 14 | $32K |
| Lansoprazole Generic | 45 | 74 | 12 | $1,456 |
| Atorvastatin Calcium Generic | 43 | 113 | 14 | $377 |
| Rosuvastatin Calcium Generic | 39 | 89 | 14 | $300 |
| Mycophenolate Mofetil Generic | 37 | 67 | 12 | $4,357 |
Brand drugs: - claims; generic drugs: 1,908 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Jennifer L Vise $134 ($134 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $115.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.